|41.98||+0.41 / +0.99%|
As of 4:00pm ET
|41.55||-0.4309 / -1.03%|
The 8 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 43.00, with a high estimate of 50.00 and a low estimate of 38.00. The median estimate represents a +2.43% increase from the last price of 41.98.
The current consensus among 8 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.